Christopher P. Guise
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 25
- Biotechnology top 1%
- Cancer Research and Treatments 17
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 9
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 5
- Cell Biology top 10%
- Aldose Reductase and Taurine 9
- Oncology top 10%
-
- Virus-based gene therapy research 9
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Adam V. PattersonWilliam R. WilsonJeff B. SmaillAlexandra M. MowdayMaria R. AbbattistaAmir AshoorzadehEva I. HydePeter F. Searle
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)Biochemistry (2 papers)
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
Christopher P. Guise
51 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 612
- Biotechnology 334
- Molecular Biology 858
- Cell Biology 172
- Oncology 239
Countries citing papers authored by Christopher P. Guise
This map shows the geographic impact of Christopher P. Guise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Guise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Guise more than expected).
Fields of papers citing papers by Christopher P. Guise
This network shows the impact of papers produced by Christopher P. Guise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Guise. The network helps show where Christopher P. Guise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher P. Guise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 21 | |
| 4 | 2019 | 7 | |
| 5 | 2017 | 34 | |
| 6 | 2017 | 24 | |
| 7 | 2015 | 27 | |
| 8 | 2014 | 29 | |
| 9 | 2013 | 15 | |
| 10 | 2013 | 18 | |
| 11 | 2013 | 40 | |
| 12 | 2013 | 43 | |
| 13 | 2012 | 25 | |
| 14 | 2011 | 160 | |
| 15 | 2010 | 141 | |
| 16 | 2010 | 43 | |
| 17 | 2009 | 60 | |
| 18 | 2009 | 27 | |
| 19 | 2007 | 17 | |
| 20 | Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954. | 2003 | 60 |
About Christopher P. Guise
Christopher P. Guise is a scholar working on Biotechnology, Cancer Research and Cell Biology, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (25 papers), Cancer Research and Treatments (17 papers), Virus-based gene therapy research (9 papers), Aldose Reductase and Taurine (9 papers), Epigenetics and DNA Methylation (9 papers), RNA Interference and Gene Delivery (5 papers), CRISPR and Genetic Engineering (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Cancer Research (612 citations), Biotechnology (334 citations) and Molecular Biology (858 citations). Christopher P. Guise has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Adam V. Patterson, William R. Wilson, Jeff B. Smaill, Alexandra M. Mowday, Maria R. Abbattista, Amir Ashoorzadeh, Eva I. Hyde, Peter F. Searle, David F. Ackerley and Jane I. Grove. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.